Alison Douglass > Goodwin > Boston, United States > Lawyer Profile
Goodwin Offices
100 NORTHERN AVENUE
BOSTON MA 02210
MASSACHUSETTS
United States
- Firm Profile
- Go to...
Alison Douglass
Position
Partner
Career
Alison Douglass, a partner in Goodwin’s Complex Business Litigation and Dispute Resolution, Financial Industry Litigation and ERISA Litigation practices, focuses her practice on a wide array of complex commercial litigation, primarily in the areas of ERISA, mutual fund and securities litigation. Alison has been selected for inclusion to Chambers USA: America’s Leading Lawyers for Business in ERISA Litigation since 2014 and clients laud her abilities, saying: “She is an extremely talented litigator who excels as an advocate and on case strategy.” She has also been recognized by The Legal 500 and named a “Rising Star” by Law & Politics and Boston magazine.
Alison represents clients in all phases of litigation, including pre-litigation counseling and trial and appellate matters in federal courts across the county and in regulatory investigations and governmental proceedings, including before the US Department of Labor and the SEC. As part of her ERISA and mutual fund litigation practice, Alison is involved in a broad range of class actions, derivative actions and multi-proceeding litigations. She also regularly advises clients on risk management and insurance coverage matters. Alison joined Goodwin in 2005 and serves on the firm’s Partnership Committee.
Education
JD, 2000, Fordham University School of Law (cum laude, Order of the Coif) / BA, 1995, Middlebury College (cum laude)
Lawyer Rankings
United States > Labor and employment > ERISA litigation
(Leading partners)Goodwin specializes in defending financial services companies, as well as other plan sponsors and service providers in class actions against allegations of breach of ERISA fiduciary duties, especially in relation to plan fees and investments. The firm is noted for its capital markets, healthcare and financial services experience, with the team securing victories for clients including MetLife, which resulted in the dismissal of a novel challenge to a plan’s use of prescription-drug rebates. The team’s appellate expertise is noted, with members including Boston-based Alison Douglass and Jaime Santos, in Washington DC, representing clients before circuit courts across the country and before the US Supreme Court. Also in Boston, James Fleckner has been active in defending against new ERISA litigation trends, including pension retirement benefit obligations to insurance carriers that have been filed and class action claims challenging the retention of foreign tax credits under the Internal Revenue Code relating to ERISA assets. Also in Washington DC, Michael Isenman represents a variety of clients including mutual funds and investment advisers in litigation and regulatory contexts including ERISA class actions and shareholder derivative demands and litigation. Christina Hennecken and David Rosenberg are key names.
Lawyer Rankings
- Leading partners United States > Labor and employment > ERISA litigation
- ERISA litigation United States > Labor and employment
Top Tier Firm Rankings
- Industry focus > Cannabis
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Intellectual property > Patents: licensing
- M&A/corporate and commercial > Private equity buyouts: middle-market (Up to $500m)
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- Finance > Capital markets: equity offerings
- Dispute resolution > E-discovery
- Labor and employment > ERISA litigation
- Finance > Fintech
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Intellectual property > Patents: litigation (full coverage)
- Real estate > Real estate
- Dispute resolution > Securities litigation: defense
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- M&A/corporate and commercial > Shareholder activism
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Capital markets: debt offerings
- International trade and national security > CFIUS
- Finance > Commercial lending
- M&A/corporate and commercial > Corporate governance
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Financial services litigation
- Antitrust > Merger control
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Tax > US taxes: non-contentious
- Labor and employment > Workplace and employment counseling
- International trade and national security > Customs, export controls and economic sanctions
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Intellectual property > Patents: litigation (International Trade Commission)
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Healthcare > Service providers
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Real estate > Real estate finance
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Finance > Financial services regulation